AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
2.090
-0.140 (-6.28%)
At close: Apr 1, 2025, 4:00 PM
2.190
+0.100 (4.78%)
After-hours: Apr 1, 2025, 7:57 PM EDT

AbCellera Biologics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2018
Market Capitalization
6238651,6572,8984,02710,832
Upgrade
Market Cap Growth
-47.77%-47.77%-42.83%-28.02%-62.83%-
Upgrade
Enterprise Value
632949522,1063,30510,829
Upgrade
Last Close Price
2.092.935.7110.1314.3040.24
Upgrade
PE Ratio
---18.2826.24127.29
Upgrade
Forward PE
----51.81-
Upgrade
PS Ratio
21.3330.0243.575.9710.7346.46
Upgrade
PB Ratio
0.590.821.442.353.9313.04
Upgrade
P/TBV Ratio
0.900.901.682.754.8515.84
Upgrade
P/FCF Ratio
--14.0221.63832.15
Upgrade
P/OCF Ratio
--10.4516.46477.40
Upgrade
EV/Sales Ratio
2.1710.1925.034.348.8146.45
Upgrade
EV/EBITDA Ratio
--8.6215.1067.32
Upgrade
EV/EBIT Ratio
--9.3616.1769.40
Upgrade
EV/FCF Ratio
--10.1917.76831.92
Upgrade
Debt / Equity Ratio
0.060.060.070.070.040.01
Upgrade
Debt / EBITDA Ratio
---0.320.180.03
Upgrade
Debt / FCF Ratio
---0.400.220.34
Upgrade
Asset Turnover
0.020.020.030.340.320.45
Upgrade
Inventory Turnover
---108.8169.8671.97
Upgrade
Quick Ratio
8.958.956.938.377.447.81
Upgrade
Current Ratio
9.819.817.338.677.717.86
Upgrade
Return on Equity (ROE)
-14.75%-14.75%-12.27%14.03%16.54%28.29%
Upgrade
Return on Assets (ROA)
-12.41%-12.41%-9.79%9.83%10.99%18.95%
Upgrade
Return on Capital (ROIC)
-15.03%-15.03%-11.65%11.81%13.44%22.89%
Upgrade
Return on Capital Employed (ROCE)
---15.80%17.10%17.30%
Upgrade
Earnings Yield
-26.15%-18.82%-8.84%5.47%3.81%1.10%
Upgrade
FCF Yield
-30.02%-21.60%-7.29%7.13%4.62%0.12%
Upgrade
Buyback Yield / Dilution
-1.78%-1.79%8.15%1.09%-20.96%-73.88%
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q